Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Allelix describes dopamine D4 ligands for schizophrenia

Aug. 23, 1996

Zeneca files for U.K. marketing approval for Seroquel

Aug. 23, 1996

Allelix Biopharmaceuticals reports selective M1/M2 receptor ligands

Aug. 23, 1996

Draxis Health seeks Canadian approval of modafinil

Aug. 23, 1996

More tachykinin NK1 antagonists reported by Sandoz

Aug. 23, 1996

Calpain inhibitor PD-150606 shows neuroprotective effects

Aug. 16, 1996

SmithKline Beecham takes over Bradycor development

Aug. 16, 1996

Taisho describes NGF production promotors

Aug. 16, 1996

GABA-A receptor ligands disclosed by Synthelabo

Aug. 16, 1996

Marinol potential in Alzheimer's disease patients reported at congress

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...